Time to take treatment seriously

Slides:



Advertisements
Similar presentations
Mass Distribution of Heavily Subsidised NRT: the New Zealand Experience Nick Wilson* (Otago University, Wellington, NZ) Michele Grigg (The Quit Group,
Advertisements

2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
Community Pharmacy Workbook
WHO FCTC Art 14 Draft guidelines realised September.
Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
SETTING OUR COMPASS QuitlineNC: Partnering to Improve Tobacco Cessation in North Carolina.
The Role of Quitlines in Comprehensive Tobacco Cessation: Where are We Now; Where are We Going; and How do We Get There? Tamatha Thomas-Haase, MPA Manager,
Quit with Us: A social marketing intervention to motivate and assist individuals to stop smoking using Tenovus retail outlets. Maura Matthews and Dr Sioned.
The Spanish Quitline Network. The case study of the Catalonia Quitline Dolors Marin Tuyà Psychologist specialist in Clinical Psychology Public Health Directorate.
Session 7—Presentation and Panel Discussion International Quitline Institute 2011 Conference October 11, 2011 Seattle, Washington National Center for Chronic.
GATS CHINA LAUNCH OF RESULTS Lin Xiao China CDC Tabacco Control Office Lin Xiao China CDC Tabacco Control Office.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
An Oral Health Needs Assessment of Prisoners in HMP Brixton Ellie Heidari Senior Clinical Teacher Sedation & Special Care Dentistry King’s College London.
Presentation One: Areas of development and potential problems for ASH Deborah Arnott Director.
1 Progress in the development, monitoring, and implementation of tobacco dependence treatment around the world 13 March, 2013 Boston, MA.
ITC Bangladesh Project Geoffrey T. Fong, Ph.D. Department of Psychology University of Waterloo ITC-TTURC Project Annual Meeting Portland, Oregon—March.
Martin Raw University of Nottingham, UK, Federal University of Sao Paulo, Brazil UKNSCC June 2013 A survey of tobacco cessation support in 121 countries.
Tobacco Use Prevention and Controlin Iowa Tobacco Use Prevention and Control in Iowa Iowa Department of Public Health Division of Tobacco Use Prevention.
Information for Patients and Public Workshop 15th May 2012 Working with your Patient Information Centre Christine McRoy Library & Information Services.
Implementing the NICE guidelines for smoking cessation in secondary care: From rhetoric to reality Debbie Robson & Ann McNeill Addictions Department, Institute.
An Updated Algorithm for Choosing Among Smoking Cessation Treatments John R. Hughes University of Vermont, USA
The Alabama Tobacco Quitline and July 22, 2010.
North American Quitline Consortium Drill Down Session Strategies for Improving Public Health/Health Care Partnerships in Quitline Operations May 2, 2005.
Environmental CO Capture Influences Smoke Free Homes A case study Presenters: Tracy Rowland, Health Programme Advisor, Public Health Dorset Martin Marsh,
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Linking Together to.
ABSTINENCE AND RELAPSE AMONG SMOKERS WHO USE VARENICLINE FOR QUITTING—A POOLED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Shade Agboola, Ann McNeill, Tim.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
New Plan Provisions- Medical Plan Changes. 2 Tobacco/Smoking Cessation Support “Clearing the Air” to a Tobacco-Free UC on January 2, 2014 Effective January.
The Czech Experience Miroslav Zmeskal Coordinator of Quitline Czech Coalition Against Tobacco.
Linda A. Bailey, JD, MHS How Regional Networks Can Support Quitlines 11/11/2011.
 2007 Johns Hopkins Bloomberg School of Public Health Section B Tobacco Control Experiences in Developing Countries.
Developing and implementing a new approach to smoking at Kings College Hospital: a joined up approach for South Londoners Dr Irem Patel Consultant Respiratory.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers The Wisconsin Tobacco.
Tackling Obesity in NSW An LHD Perspective on integrating prevention into routine care John Wiggers Director, Population Health, Hunter New England Local.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
This presentation is the intellectual property of the authors. Contact for permission to reprint and/or This.
Future Tobacco Control Policy Future Directions of Tobacco Control: An advocacy NGO perspective Becky Freeman, Director.
1 Cost efficacy of smoking cessation interventions Robert West University College London Logroño, October
1 News from the Smoking Toolkit Study: December 2012 University College London December 2012 Robert West.
1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.
Smoking in England Robert West Jamie Brown University College London 1.
Effectiveness of interventions to aid smoking cessation Robert West University College London September 2008.
1 Cancer Research UK smoking cessation programme at UCL: Robert West University College London London October 2007.
1 A national initiative to help smokers quit: the English experience Robert West University College London Stockholm, April 2008.
Real World Experience Panel: Engaging the Patient Robert J. West, PhD Professor of Health Psychology Director of Tobacco Studies Cancer Research UK Health.
1 The role of interventions and policies to promote behaviour change University College London June 2014 Robert West.
1 Tobacco addiction treatment: from evidence to practice University College London November 2012 Susan Michie Robert West.
1 Products for smoking cessation University College London March 2014 Robert West.
1 Cytisine for smoking cessation Robert West John Stapleton Magda Cedzynska Paul Aveyard Witold Zatonski.
1 Identifying affordable, practicable and effective clinical interventions to promote smoking cessation University College London February 2013 Robert.
Hot topics in smoking cessation Robert West University College robertjwest 1.
1 Effects on smoking cessation of a national strategy to maximise NRT usage: the UK experience Robert West University College London WCTOH July 2006 Washington.
BSHS 452 Week 1 DQ 2 Check this A+ tutorial guideline at 452/BSHS-452-Week-1-DQ-2 How can you convince the funder.
ACTION PLAN AUDIT QUESTIONS HCC AP Q 1-5
Smoking and smoking cessation in the real world
Community, Health and Social Care Directorate
Nick Wilson* (Otago University, Wellington)
Tim McAfee, M.D., M.P.H. Director, CDC Office on Smoking and Health
Policies to reduce smoking prevalence in England
Bruce J Kirenga, Rupert Jones and Siân Williams
The very best support for stopping smoking
QuitlineNC Funding.
The very best support for stopping smoking
Establishing the Infrastructure for Radiation Safety Preparatory Actions and Initial Regulatory Activities.
Associate Professor Natalie Walker
Tobacco Cessation Coverage
Smoking cessation Felix K. Karthik.
Director, Division of Health Sciences, Brunel University London
Challenges and outcomes of implementing smoke-free grounds policy in a mental health setting Fiona Kean NHS Lothian.
Should we now focus on 'the endgame' for tobacco control in the UK?
Presentation transcript:

Time to take treatment seriously Martin Raw Director, International Centre for Tobacco Cessation Visiting Professor, New York University Medical School Madrid June 2018 1

Interests statement Kapka Nilan was funded by UK Centre for Tobacco and Alcohol Studies The ICTC was funded by Pfizer & the InterAmerican Heart Foundation 2

Survey team Martin Raw, Ann McNeill, Rachael Murray, Tricia McKeever, Kapka Nilan University of Nottingham & Kings College London Sample 172 FCTC Parties 142 replies 83% response rate 3

Basic infrastructure e Does your country % Yes Have an officially identified person responsible for treatment? 54 Have an official national treatment strategy? 32 Have national treatment guidelines? 40 Have a clearly identified budget for treatment? 25 Offer to help healthcare workers to stop using tobacco? 44 Mandate recording tobacco use in medical notes 30 e Check n 4

Components of national treatment system Does your country % Yes Run mass media campaigns promoting cessation? 13 Integrate brief advice in existing services? 44 Have a national telephone quitline? 23 Have nationwide specialised treatment facilities? 26 Have specialised treatment facilities but only in selected areas? 37 Have cessation support via text messaging? 17 Check n 5

Availability of medications by income level % Yes All High UM LM Low NRT gum 72 96 60 61 53 Bupropion 90 58 39 18 Varenicline 54 88 48 36 6 Cytisine 14 10 13 19 12 High=High income countries; UM=Upper middle income countries; LM=Lower middle income countries; Low=Low income countries 6

Affordability of medications by income level % Yes All High UM LM Low NRT gum 66 88 58 45 33 Bupropion 57 73 43 36 Varenicline 54 77 32 15 Cytisine 68 80 50 High=High income countries; UM=Upper middle income countries; LM=Lower middle income countries; Low=Low income countries 7

Specialised treatment provision by income level % Yes High UM LM Low Has nationwide treatment services 55 (36) 20 (19) 6 (0) 0 (0) High=High income countries; UM=Upper middle income countries; LM=Lower middle income countries; Low=Low income countries 8

Changes in provision from 2012 to 2015 Question 2012 n 2015 Government official responsible for cessation? 40 53 Treatment budget? 22 23 Treatment guidelines? 46 55 Mandatory recording tobacco use in patients’ notes? 21 26 Healthcare workers offered help to stop smoking? 42 Mass media campaigns promoting cessation? 54 National free quitline? 29 30 Specialised cessation services covering the whole country or in selected areas? 68 9

10

11

Availability of ecigarettes by income level % Yes All High UM LM Low Overall 79 90 80 47 Internet 67 82 69 66 24 Shops 53 65 46 57 29 Pharmacies 21 33 15 17 6 High=High income countries; UM=Upper middle income countries; LM=Lower middle income countries; Low=Low income countries; these data are being written up for publication by John Wang, whom we thank sincerely 12

Availability of medications by income level % Yes All High UM LM Low NRT gum 72 96 60 61 53 Bupropion 90 58 39 18 Varenicline 54 88 48 36 6 Cytisine 14 10 13 19 12 Ecigs 79 80 24 High=High income countries; UM=Upper middle income countries; LM=Lower middle income countries; Low=Low income countries 13

Some issues for discussion Treatment is not taken seriously (including by tobacco control funders) Implementation is slow and cost / perceived cost is an issue All countries could be doing some of the basics Is it ethical to increase price and ban smoking in public spaces but not offer help to those that need it? Is it time to consider the potential of reduced risk products? 14

Thank you martin@martinraw.com 15